CELC vs PSA · $4.33B cap vs rev $4.82B
Celcuity LLC (CELC) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Celcuity LLC (CELC) is a biotechnology company listed on NASDAQ.
PSA (PSA) common stock.
CELC does not have a complete income-statement cache yet.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
CELC currently screens at market cap $4.33B. PSA currently screens at market cap $0.
Not investment advice. Open the CELC and PSA stock pages for the full models.
Not investment advice.